HOME >> MEDICINE >> NEWS
Study documents decline in rare paralytic disorder linked to influenza vaccination

The number of reported cases of Gillain-Barre syndrome (a rare paralytic disorder) that occur following influenza vaccination has decreased over the past 12 years, according to a study in the November 24 issue of JAMA.

Guillain-Barr syndrome (GBS) is a paralytic disorder in which the body's immune system affects part of the peripheral nervous system, according to background information in the article. The first symptoms include varying degrees of weakness or tingling sensations in the legs followed by progressive weakness. Concerns about the risk of developing GBS following influenza vaccination have been present since an association was first noticed during the 1976-1977 A/New Jersey ("swine influenza") season. Evidence for a relationship between GBS and other influenza vaccines, however, has been less clear. GBS remains the most frequent neurological condition reported after influenza vaccination to the Vaccine Adverse Events Reporting System (VAERS) since its inception in 1990.

Penina Haber, M.P.H., of the Centers for Disease Control and Prevention, Atlanta, and colleagues evaluated trends of reports to VAERS of GBS following influenza vaccination in adults. Reports of GBS in persons 18 years or older following influenza vaccination were evaluated for each influenza season from July 1, 1990, through June 30, 2003. The number of people vaccinated was estimated from the National Health Interview Survey and U.S. census data. Beginning in 1994, active follow-up was conducted to verify GBS diagnosis and obtain other clinical details.

The researchers found that from July 1990 through June 2003, VAERS received 501 reports of GBS following influenza vaccination in persons at least 18 years old. Annual reporting rates of GBS per 100, 000 influenza vaccinations declined from a high of 0.17 in 1993-1994 to a low of 0.04 in 2002-2003, a 4-fold decrease. A GBS diagnosis was confirmed in 82 percent of reports. Preceding illness within 4 weeks of vacc
'"/>

Contact: CDCs Press Office
404-639-3286
JAMA and Archives Journals
23-Nov-2004


Page: 1 2

Related medicine news :

1. Study of energy and health in Africa focuses spotlight on charcoal and forest management
2. Study shows promise in identifying kidney failure
3. Study shows patch therapy may be as effective as oral medications
4. Study shows soy is well accepted in school lunches
5. Study finds that coordinating care of chronically ill patients does not increase liability
6. Study provides new estimates of the causes of child mortality worldwide
7. Study finds factors linked to substance use disorder relapse among health care professionals
8. Study finds majority of women willing to accept cervical cancer vaccine for self and children
9. Study shows use of budesonide reduced the risk of asthma related events by 40% in children
10. Study shows risk of cardiac death after radiation for breast cancer has dramatically decreased
11. Study shows acrylamide in baked and fried food does not increase risk of breast cancer in women

Post Your Comments:
(Date:11/22/2014)... 2014 Recently, UWDress.com, a successful wedding dress ... guest attire in order to prepare for the wedding ... to 70% off. , UWDress.com is a reliable company ... beautiful, especially the new items -- formal wedding guest attire. ... current market, including superstar and princess. As one of the ...
(Date:11/22/2014)... New York, NY (PRWEB) November 22, 2014 ... Australia’s Therapeutics Goods Administration (TGA) approved it for ... Glutathione was approved and listed within the Therapeutic ... http://www.comlaw.gov.au/Details/F2014L01277 , Kyowa Hakko’s Setria® Glutathione ... Chem, a biotech specialist that sources and imports ...
(Date:11/22/2014)... PITTSBURGH, PA (PRWEB) November 22, 2014 ... about the pain caused by the machine," said an ... injury, she had to go back a second time ... my invention idea." , She developed the patent-pending MAMO ... for breast cancer. The design saves the patient from ...
(Date:11/22/2014)... 2014 Lipitor lawsuits ( http://www.lipitorlawsuitcenter.com/ ) ... allegedly developed Type 2 diabetes due to its use ... now underway in U.S. District Court, District of South ... the litigation will convene its next Status Conference on ... Lead Counsel for Plaintiffs and Defendants to meet and ...
(Date:11/22/2014)... The Sports Conflict Institute is pleased to ... team of conflict resolution professionals. Baroff comes to SCI as ... has over 30 years experience as an arbitrator, educator, and ... to connect with SCI and bring my conflict resolution skills ... with a complete sports focus,” says Baroff. , “Roy has ...
Breaking Medicine News(10 mins):Health News:Formal Wedding Guest Attire Added to UWDress.com 2Health News:Setria® Glutathione Now Available in Australia 2Health News:Setria® Glutathione Now Available in Australia 3Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 2Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 3Health News:SCI Announces New Team Member Roy Baroff 2Health News:SCI Announces New Team Member Roy Baroff 3
(Date:11/21/2014)... WOODLANDS, Texas , Nov. 21, 2014  Lexicon ... the pricing of its previously announced underwritten public offering ... to an effective shelf registration statement. The offering will ... public offering price of $1.005 per share.  Lexicon has ... up to 7,462,687 additional shares of common stock.  All ...
(Date:11/18/2014)... 2014  NxStage ® Medical Inc. (Nasdaq: ... innovative dialysis products , today announced the ... for the in-center, hemodialysis market.  Streamline Express features ... to reduce the amount of labor required for ... touch point contamination sites.  The dialyzer enables achievement ...
(Date:11/18/2014)... 2014  Sanguine Biosciences – a biotechnology company ... recruitment – will use its proprietary mobile application ... Inc. find and recruit people diagnosed with Congenital ... to participate in voluntary research, which will be ... hopefully aid in informing the development of potential ...
Breaking Medicine Technology:Lexicon Announces Pricing Of Common Stock Offering 2Lexicon Announces Pricing Of Common Stock Offering 3NxStage Launches New Streamline Express Dialyzer With Pre-attached Blood Tubing Set 2Sanguine's Mobile Application to Assist Recruitment for Pfizer Inc. Chronic Pain Research 2
Cached News: